Objective To understand the global patent overview of sacituzumab govitecan and provide valuable patent information for domestic enterprises and research institutions that pay attention to sacituzumab govitecan.Methods Based on the patent data of the HimmPat database, we analyzed the number of patent applications, main applicants, technological themes, layout of original research enterprises, and key patents of sacituzumab govitecan.Results A total of 102 patents were obtained. The main applicant is the original research enterprise Immunomedics, Inc., which has mastered the key technologies in the fields of compounds, preparation methods, treatment methods, and combination therapy, and has carried out the corresponding layout around the world. With the launch of drugs, more research on applications received attention. More and more researchers will submit more applications in the field of research on sacituzumab govitecan.Conclusion Domestic research institutions and pharmaceutical companies that focus on sacituzumab govitecan can conduct research from the perspectives of drug treatment methods, combination therapy, compound preparation methods, synthesis processes, and new drug uses, preparing for generic drugs on one hand, and forming intellectual property rights with core values for the other hand.